Health complications for obese kidney donors
Siemens Healthcare announced that data from a new study published in the American Cancer Society journal Cancer, supports using the Siemens Serum HER-2/neu test to monitor patients with an aggressive type of metastatic breast cancer. This non-invasive blood test can be used to help monitor the widely-used Herceptin(R) therapy. Metastatic cancer is an advanced stage
Full Post: Study suggests Siemens non-invasive blood test may have a role in monitoring breast cancer patients’ response to Herceptin
Individuals who are obese face certain risks when donating their kidneys, but their kidney function remains strong one year later, according to a paper being presented at the American Society of Nephrology’s 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.
As the waiting list for kidney transplants grows, transplant centers are working to facilitate more live donor transplantations. However, there are many unanswered questions related to the potential long-term risks of kidney donation for donors with risk factors for future kidney disease - such as obesity.
To investigate the issue, Peter Reese, MD, and his colleagues at the University of Pennsylvania in Philadelphia, Pennsylvania, report on the use of kidneys donated by live obese and non-obese individuals at transplant centers across the United States. The study included 2004-2005 registry data from the Organ Procurement and Transplantation Network. In all, the investigators analyzed data from more than 5,300 donors, among whom nearly 1,200 (22.5%) were obese.
The study revealed that obesity is common among live donors, particularly among African- and Hispanic-American donors, who also are more likely to develop kidney disease. Additionally, the research indicates that compared with non-obese donors, obese donors have higher blood pressure prior to kidney donation.
To compare the health of obese and non-obese donors after surgery, the investigators measured blood pressure, hypertension status, and kidney function at six and twelve months after kidney donation. Obese donors had slightly higher blood pressure and were more likely to be hypertensive than non-obese donors. However, obese donors did not have worse kidney function than non-obese donors.
The study’s major limitation was missing data on donor outcomes at follow-up. For instance, approximately 40% of donors had no data on kidney function reported at 6 months.
The authors stress that while this study indicates that obese individuals do not suffer from serious short-term adverse outcomes following kidney donation, the long-term risks to obese donors are uncertain. Uncovering these risks is important because many potential donors are strongly motivated to help loved ones but should also be aware of the risks to themselves. “Transplant centers must work hard to inform live donors about risks, but there are many unknowns,” said Reese. He noted that studies on health outcomes at 10 or 20 years after donation would help clarify the risks to obese donors, but such long-term data are currently not available.
The study abstract, “Peri-Operative Complications and 1-Year Outcomes for Obese Live Kidney Donors,” (F-FC198) will be presented as part of a Free Communications session on the topic of “Care Delivery in Kidney Transplantation and the Living Kidney Donor” on Friday, November 7 at 5:36 p.m. in Room 111 of the Pennsylvania Convention Center in Philadelphia, PA.
ASN is a not-for-profit organization of 11,000 physicians and scientists dedicated to the study of nephrology and committed to providing a forum for the promulgation of information regarding the latest research and clinical findings on kidney disease. ASN Renal Week 2008, the largest nephrology meeting of its kind, will provide a forum for 11,000 nephrologists to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Renal Week 2008 will take place November 4 - November 9 at the Pennsylvania Convention Center in Philadelphia, PA.
When a woman contemplates donating a kidney, she need not worry about any potential health risks it might pose to a future pregnancy, according to a paper being presented at the American Society of Nephrology’s 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania. The research revealed that a woman who has donated a kidney
Full Post: Maternal and fetal outcomes in kidney donors are similar to non-donors
Introducing presumed consent or opt-out system may increase organ donation rates, suggests a new systematic review published on BMJ.com. There is currently insufficient supply of donor organs to meet the demand for organ transplantations in the UK. The number of patients registered for a transplant continues to increase. In March 2008, 7,655 patients were on
Full Post: Presumed consent or opt-out system may increase organ donation rates
Gender matching between donors and recipients is important to short- and long-term survival in heart transplantation, according to a retrospective study presented at the American Heart Association’s Scientific Sessions 2008. “Heart size would seem to be the most obvious factor; beyond that, no one knows why sex matching is important to transplant survival,” said Eric
Full Post: Gender matching between donors and recipients important to survival in heart transplantation
A Johns Hopkins transplant surgeon has found strong evidence that women over 45 are significantly less likely to be placed on a kidney transplant list than their equivalent male counterparts, even though women who receive a transplant stand an equal chance of survival. “As woman age, that discrepancy widens to the point where woman over
Full Post: Older women less likely than men to be listed on a kidney transplant list
Using stents to open up kidney arteries is commonly done in patients with atherosclerotic renovascular disease, but the procedure provides no benefit, according to a paper being presented at the American Society of Nephrology’s 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania. Patients with renovascular disease due to atherosclerosis have narrowed blood vessels leading
Full Post: Stents no help for patients with narrow kidney arteries